Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Secures US$27M to Advance Phase 3 OA Trial

Jul 1, 2025 at 2:52 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment